Research graph
References from The NF-κB pathway in inflammatory responses in preeclampsia. Local targets link to admitted publications; unresolved targets remain external evidence.
Earlier onset of proteinuria or hypertension is a predictor of progression from gestational hypertension or gestational proteinuria to preeclampsia.
10.1038/s41598-021-92189-w · 2021 · External reference
Resolution of hypertension and proteinuria after preeclampsia.
10.1097/aog.0b013e3181c14e3e · 2009 · External reference
Risk factors and effective management of preeclampsia.
2015 · External reference
Preeclampsia diagnosis and management.
10.1016/j.bpa.2022.02.003 · 2022 · External reference
Preeclampsia and late fetal growth restriction.
2021 · External reference
Maternal and fetal risk factors affecting perinatal mortality in early and late fetal growth restriction.
10.1016/j.tjog.2015.03.006 · 2015 · External reference
Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease: a review.
10.3390/jcm11206048 · 2022 · External reference
Immunology and genetic of preeclampsia.
2006 · External reference
Genetic and epigenetic factors contribute to the onset of preeclampsia.
10.1016/j.mce.2007.11.022 · 2008 · External reference
Influences of environmental factors during preeclampsia.
10.1152/ajpregu.00020.2020 · 2020 · External reference
Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies.
10.1097/00006254-199806000-00023 · 1998 · External reference
Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia.
10.1016/j.ajog.2021.11.019 · 2022 · External reference
Diagnosis and management of preeclampsia.
2004 · External reference
Cross‐talk between oxidative stress and inflammation in preeclampsia.
10.1155/2019/8238727 · 2019 · External reference
The role of inflammation in the pathogenesis of preeclampsia.
10.1155/2020/3864941 · 2020 · External reference
Vascular dysfunction in preeclampsia.
10.3390/cells10113055 · 2021 · External reference
Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia.
10.1016/j.bbadis.2020.165961 · 2020 · External reference
Advances in pathogenesis of preeclampsia.
10.1007/s00404-024-07393-6 · 2024 · External reference
Cytokine-polymorphisms associated with preeclampsia: a review.
10.1097/md.0000000000030870 · 2022 · External reference
The role of sirtuin-1 (SIRT1) in the physiology and pathophysiology of the human placenta.
10.3390/ijms242216210 · 2023 · External reference
NF-κB: blending metabolism, immunity, and inflammation.
10.1016/j.it.2022.07.004 · 2022 · External reference
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.
2019 · External reference
NF-κB, inflammation, and metabolic disease.
10.1016/j.cmet.2010.12.008 · 2011 · External reference
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase.
10.1038/sj.emboj.7600244 · 2004 · External reference
Activation of NF-κB in placentas of women with preeclampsia.
10.3109/10641955.2011.642436 · 2012 · External reference
New regulators of NF-κB in inflammation.
10.1038/nri2423 · 2008 · External reference
NF-κB: a key role in inflammatory diseases.
10.1172/jci11830 · 2001 · External reference
Regulation of SIRT1 and its roles in inflammation.
10.3389/fimmu.2022.831168 · 2022 · External reference
Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1.
10.1016/j.mad.2009.06.004 · 2009 · External reference
SIRT1: a novel protective molecule in pre-eclampsia.
10.7150/ijms.73012 · 2022 · External reference
Candesartan targeting of angiotensin II type 1 receptor demonstrates benefits for hypertension in pregnancy via the NF‑κB signaling pathway.
2018 · External reference
The targeting of nuclear factor kappa B by drugs adopted for the prevention and treatment of preeclampsia.
10.3390/ijms23052881 · 2022 · External reference
Canonical, non-canonical and atypical pathways of nuclear factor кb activation in preeclampsia.
10.3390/ijms21155574 · 2020 · External reference
Preeclampsia-current management and future approach.
10.2174/1389201019666180925120109 · 2018 · External reference
Obesity and preeclampsia: the potential role of inflammation.
2001 · External reference
Cigarette smoking blocks the protective expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation.
10.1371/journal.pone.0008225 · 2009 · External reference
Advances in pathogenesis of preeclampsia.
10.1007/s00404-024-07393-6 · ExternalCitation · doi-reference
Progress in the understanding of the pathophysiology of immunologic maladaptation related to early-onset preeclampsia and metabolic syndrome related to late-onset preeclampsia.
10.1016/j.ajog.2021.11.019 · ExternalCitation · doi-reference
Oxidative stress and mitochondrial dysfunction in early-onset and late-onset preeclampsia.
10.1016/j.bbadis.2020.165961 · ExternalCitation · doi-reference
Preeclampsia diagnosis and management.
10.1016/j.bpa.2022.02.003 · ExternalCitation · doi-reference
NF-κB, inflammation, and metabolic disease.
10.1016/j.cmet.2010.12.008 · ExternalCitation · doi-reference
NF-κB: blending metabolism, immunity, and inflammation.
10.1016/j.it.2022.07.004 · ExternalCitation · doi-reference
Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1.
10.1016/j.mad.2009.06.004 · ExternalCitation · doi-reference
Genetic and epigenetic factors contribute to the onset of preeclampsia.
10.1016/j.mce.2007.11.022 · ExternalCitation · doi-reference
Maternal and fetal risk factors affecting perinatal mortality in early and late fetal growth restriction.
10.1016/j.tjog.2015.03.006 · ExternalCitation · doi-reference
New regulators of NF-κB in inflammation.
10.1038/nri2423 · ExternalCitation · doi-reference
Earlier onset of proteinuria or hypertension is a predictor of progression from gestational hypertension or gestational proteinuria to preeclampsia.
10.1038/s41598-021-92189-w · ExternalCitation · doi-reference
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase.
10.1038/sj.emboj.7600244 · ExternalCitation · doi-reference
Immune maladaptation in the etiology of preeclampsia: a review of corroborative epidemiologic studies.
10.1097/00006254-199806000-00023 · ExternalCitation · doi-reference
Resolution of hypertension and proteinuria after preeclampsia.
10.1097/aog.0b013e3181c14e3e · ExternalCitation · doi-reference
Cytokine-polymorphisms associated with preeclampsia: a review.
10.1097/md.0000000000030870 · ExternalCitation · doi-reference
Influences of environmental factors during preeclampsia.
10.1152/ajpregu.00020.2020 · ExternalCitation · doi-reference
Cross‐talk between oxidative stress and inflammation in preeclampsia.
10.1155/2019/8238727 · ExternalCitation · doi-reference
The role of inflammation in the pathogenesis of preeclampsia.
10.1155/2020/3864941 · ExternalCitation · doi-reference
NF-κB: a key role in inflammatory diseases.
10.1172/jci11830 · ExternalCitation · doi-reference
Cigarette smoking blocks the protective expression of Nrf2/ARE pathway in peripheral mononuclear cells of young heavy smokers favouring inflammation.
10.1371/journal.pone.0008225 · ExternalCitation · doi-reference
Preeclampsia-current management and future approach.
10.2174/1389201019666180925120109 · ExternalCitation · doi-reference
Activation of NF-κB in placentas of women with preeclampsia.
10.3109/10641955.2011.642436 · ExternalCitation · doi-reference
Regulation of SIRT1 and its roles in inflammation.
10.3389/fimmu.2022.831168 · ExternalCitation · doi-reference
Vascular dysfunction in preeclampsia.
10.3390/cells10113055 · ExternalCitation · doi-reference
Canonical, non-canonical and atypical pathways of nuclear factor кb activation in preeclampsia.
10.3390/ijms21155574 · ExternalCitation · doi-reference
The targeting of nuclear factor kappa B by drugs adopted for the prevention and treatment of preeclampsia.
10.3390/ijms23052881 · ExternalCitation · doi-reference
The role of sirtuin-1 (SIRT1) in the physiology and pathophysiology of the human placenta.
10.3390/ijms242216210 · ExternalCitation · doi-reference
Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease: a review.
10.3390/jcm11206048 · ExternalCitation · doi-reference
SIRT1: a novel protective molecule in pre-eclampsia.
10.7150/ijms.73012 · ExternalCitation · doi-reference
